In 2,595 adults aged 5471, omnivorous participants produced more TMAO than vegans or vegetarians after L-carnitine consumption
Systolic blood pressure declined by 9.9 mm Hg with the combination and 3.2 mm Hg with placebo (-6.7 mm Hg difference
Emerging data suggest that glucagonlike peptide1 receptor agonists (GLP1 RAs), originally developed for glycemic control and weight management, may have direct hepatic benefits even in patients who are not visibly obese or overtly diabetic
Read the full breakdown here: To view or add a comment, sign in 87,722 followers UPDATE: Thank you to the hundreds of people who sent in photos
Thyroid hormone receptor- agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways
Hims & Hers started selling copycat GLP-1 injections in May of 2024, taking advantage of a loophole that allows pharmacies to compound versions of drugs that are on the FDAs official shortage list